Anemia
Why trials studying Anemia stopped, in this sample of ClinicalTrials.gov.
28 stopped trials with a clear reason; 93% ended for non-scientific reasons.
| Reason | Trials | Share |
|---|---|---|
| slow accrual | 12 | 43% |
| funding business | 11 | 39% |
| logistics pi | 2 | 7% |
| safety | 1 | 4% |
| manufacturing supply | 1 | 4% |
| other | 1 | 4% |
Trials
- The Sequestration of Holistic Stress Management Techniques for Adults
NCT06098755 · WITHDRAWN · slow accrual
“No Participants Enrolled” - Pyruvate Kinase (PK) Deficiency Global Longitudinal Registry: Patient-Reported Outcomes (PRO)
NCT04964323 · TERMINATED · slow accrual
“Lack of enrollment and participant compliance with surveys.” - Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging
NCT04815603 · WITHDRAWN · funding business
“The program priority for execution of this clinical trial changed prior to enrollment of the first patient. The study was not withdrawn due to any safety concerns.” - Mechanisms of EPO-induced Hypertension
NCT03810911 · TERMINATED · slow accrual
“The trial was stopped because of inability to reach target sample size.” - The Effects of One Month Consumption of Standardized Aronia Melanocarpa Extract on Anemia in Patients on Hemodialysis
NCT04208451 · TERMINATED · other
“All required data are already collected.” - Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial
NCT02564796 · TERMINATED · logistics pi
“COVID” - Uganda Birth Cohort Study
NCT04233944 · TERMINATED · funding business
“Funding constraints” - Capsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding
NCT01837030 · WITHDRAWN · funding business
“not feasible due to funding” - Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
NCT01506726 · TERMINATED · manufacturing supply
“Study drug expiration and supply shortage” - Delayed Cord Clamping in Premature Infants
NCT01018576 · TERMINATED · logistics pi
“Inadequate numbers of babies enrolled and departure of co-investigator” - Study of Erythropoietin to Treat Anemia Complicating Chronic Obstructive Pulmonary Disease
NCT00579046 · WITHDRAWN · slow accrual
“no patient recruiting” - Effect of Vitamin D Supplementation on Erythropoietin Dosage in Hemodialysis Patients Who Have Vitamin D Deficiency
NCT00915317 · WITHDRAWN · slow accrual
“Before we could start the study, we realized that many of the patients were already getting ergocalciferol. Therefore, the study was closed.” - DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)
NCT00664066 · TERMINATED · funding business
“The termination of the study is not linked to a product recall or result of any safety signal. Rather it was sponsor's commercial decision to withdraw the MA” - A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic Nephropathy
NCT00907608 · TERMINATED · slow accrual
“Due to difficulty in patient recruitment” - Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients
NCT00701714 · TERMINATED · safety
“investigation of adverse events” - Dynepo Long-Term Safety Study
NCT00514813 · TERMINATED · funding business
“The termination of the study is not linked to a product recall or result of any safety signal. Rather it was sponsor's commercial decision to withdraw the MA” - Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia
NCT00481624 · WITHDRAWN · funding business
“The study was stopped because of lack of funding.” - A Study of Mircera in Hemoglobin Control of Patients Transitioning to Dialysis.
NCT00454246 · TERMINATED · funding business
“Strategic decision unrelated to safety or efficacy” - A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
NCT00442416 · TERMINATED · funding business
“Strategic decision unrelated to safety or efficacy” - Dynepo Infrequent Dosing Study
NCT00450333 · TERMINATED · funding business
“The termination of the study is not linked to a product recall or result of any safety signal. Rather it was sponsor's commercial decision to withdraw the MA” - A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B
NCT02608060 · TERMINATED · slow accrual
“Due to poor enrollment this study was terminated prematurely.” - A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected Patients
NCT00246298 · TERMINATED · funding business
“OBI business decision not to complete any additional research in HIV.” - Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease
NCT00109291 · TERMINATED · slow accrual
“Due to slow enrollment” - The Duration Study
NCT00210730 · TERMINATED · slow accrual
“This study was stopped early due to slow enrollment.” - A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer
NCT00246597 · TERMINATED · slow accrual
“Study stopped to avoid treating enrolled subjects to hemoglobin levels higher than those specified in current labeling.” - A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy.
NCT00350090 · TERMINATED · slow accrual
“This study was stopped early due to slow enrollment.” - Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
NCT00301912 · WITHDRAWN · slow accrual
“Withdrawn because study never opened to accrual” - A Phase 2 Study to Evaluate the Safety and Effectiveness of Once Weekly or Once Every Two Week Dosing of Epoetin Alfa in Anemic Patients With Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
NCT00446602 · WITHDRAWN · funding business
“Due to company decision to focus resources on a larger, controlled study in this patient population.”
Reasons are labeled automatically and are unverified. See the methodology. This is research information, not medical advice. Search the full database.